Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

0.3378 -0.0922 (-21.44%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,953,757
Open 0.4012
Bid (Size) 0.3290 (9,800)
Ask (Size) 0.3293 (1,300)
Prev. Close 0.4300
Today's Range 0.3312 - 0.4022
52wk Range 0.3312 - 24.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants 
From Sunshine Biopharma Inc.
Via ACCESS Newswire

Performance

52-Week Range 98.6% below 52-week high
0.3378
0.3352W Low 24.3052W High
1 Week 78.3% below 1-week high
0.331W Low 1.561W High

Sunshine Biopharma Inc. - Common stock (SBFM) traded between $0.33 and $24.30 over the past 52 weeks and last traded at $0.34, 98.6% below its 52-week high. Over the past week it ranged between $0.33 and $1.56.

Past 12 Months
-19.6%
-68.7%
-82.7%
-96.6%
-97.4%
-97.8%
1W -$0.08
1M -$0.74
3M -$1.61
6M -$9.57
YTD -$12.46
1Y -$15.16

SBFM was -97.8% over the past year, -96.6% over six months, -97.4% year to date, -19.6% in the last week.

12 Months vs Market
SBFM
-97.8%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months SBFM returned -97.8% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 1.30× 3-mo avg
Today 6,953,757 3-mo avg 5.4M
1W
61.9M
1M
14.2M
3M
5.4M
6M
3.5M
YTD
2.3M
1Y
1.8M

SBFM most recently traded 6,953,757 shares against a 3-month average daily volume of 5.4M.

More News

Read More
Top stock movements in today's session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Thursday's session. ↗
Via Chartmill
Thursday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Curious about the most active stocks on Wednesday? ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Monday's session: top gainers and losers ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Monday's session: gap up and gap down stocks ↗
Via Chartmill
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
Via FinancialNewsMedia
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
From Sunshine Biopharma Inc.
Via ACCESS Newswire

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Common stock publicly traded?
Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
What exchange does Sunshine Biopharma Inc. - Common stock trade on?
Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
What is the current price of Sunshine Biopharma Inc. - Common stock?
The current price of Sunshine Biopharma Inc. - Common stock is 0.3378
When was Sunshine Biopharma Inc. - Common stock last traded?
The last trade of Sunshine Biopharma Inc. - Common stock was at 10/09/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.